|
US5505941A
(en)
*
|
1981-12-24 |
1996-04-09 |
Health Research, Inc. |
Recombinant avipox virus and method to induce an immune response
|
|
US7767449B1
(en)
|
1981-12-24 |
2010-08-03 |
Health Research Incorporated |
Methods using modified vaccinia virus
|
|
US7374768B1
(en)
|
1990-09-25 |
2008-05-20 |
Xenova Research Limited |
Viral vaccines
|
|
US6309647B1
(en)
*
|
1999-07-15 |
2001-10-30 |
Aventis Pasteur |
Poxvirus—canine dispemper virus (CDV) or measles virus recombinants and compositions and methods employing the recombinants
|
|
EP0561034B1
(en)
|
1991-08-26 |
1999-06-09 |
IMMUNO Aktiengesellschaft |
Direct molecular cloning of a modified chordopox virus genome
|
|
WO1995030018A2
(en)
*
|
1994-04-29 |
1995-11-09 |
Immuno Aktiengesellschaft |
Recombinant poxviruses with foreign polynucleotides in essential regions
|
|
FR2750865B1
(fr)
*
|
1996-06-27 |
1998-12-04 |
Rhone Merieux |
Vaccin vivant recombinant a base d'herpesvirus canin, notamment contre la maladie de carre, la rage ou le virus parainfluenza de type 2
|
|
US7294338B2
(en)
*
|
1996-07-19 |
2007-11-13 |
Merial |
Polynucleotide vaccine formula against canine pathologies, in particular respiratory and digestive pathologies
|
|
US6368603B1
(en)
*
|
1997-03-05 |
2002-04-09 |
Merial Limited |
Lyme combination compositions and uses
|
|
US6517843B1
(en)
|
1999-08-31 |
2003-02-11 |
Merial |
Reduction of porcine circovirus-2 viral load with inactivated PCV-2
|
|
FR2775601B1
(fr)
*
|
1998-03-03 |
2001-09-21 |
Merial Sas |
Vaccins vivants recombines et adjuves
|
|
US6497883B1
(en)
|
1999-06-10 |
2002-12-24 |
Merial |
Porcine circovirus recombinant poxvirus vaccine
|
|
DE60038971D1
(de)
*
|
1999-10-22 |
2008-07-03 |
Aventis Pasteur |
Verfahren zur erregung und/oder verstärkung der immunantwort gegen tumorantigene
|
|
DE60038048T2
(de)
*
|
1999-12-21 |
2009-07-09 |
Merial |
Mindestens ein cryptosporidium parvum-antigen und mindestens ein antigen eines anderen darmkrankheitserregers enthaltende zusammensetzungen und impfstoffe
|
|
WO2001074845A2
(en)
*
|
2000-03-31 |
2001-10-11 |
Aventis Pasteur Limited |
Immunogenic peptides derived from prostate-specific membrane antigen (psma) and uses thereof
|
|
DK1282702T3
(da)
|
2000-05-10 |
2007-04-02 |
Sanofi Pasteur Ltd |
Immunogene polypeptider, som er kodet af KAGE-minigener, og anvendelser deraf
|
|
US7628980B2
(en)
*
|
2000-11-23 |
2009-12-08 |
Bavarian Nordic A/S |
Modified vaccinia virus ankara for the vaccination of neonates
|
|
KR100910297B1
(ko)
|
2000-11-23 |
2009-08-03 |
버베리안 노딕 에이/에스 |
변형된 백시니아 앙카라 바이러스 변형체
|
|
US7097842B2
(en)
*
|
2000-11-23 |
2006-08-29 |
Bavarian Nordic A/S |
Modified vaccinia virus ankara for the vaccination of neonates
|
|
FR2823222B1
(fr)
|
2001-04-06 |
2004-02-06 |
Merial Sas |
Vaccin contre le virus de la fievre du nil
|
|
US20070269456A1
(en)
*
|
2001-11-05 |
2007-11-22 |
Lasher Alfred W |
DNA-based plasmid formulations and vaccines and prophylactics containing the same
|
|
US20030228327A1
(en)
*
|
2001-11-05 |
2003-12-11 |
Lasher Alfred W. |
DNA-based plasmid formulations and vaccines and prophylactics containing the same
|
|
EP1839672A3
(en)
*
|
2002-04-19 |
2007-11-21 |
Bavarian Nordic A/S |
Modified vaccinia virus Ankara for the vaccination of neonates
|
|
CA2482810C
(en)
|
2002-05-02 |
2014-06-10 |
David Lovejoy |
Teneurin c-terminal associated peptides (tcap) and methods and uses thereof
|
|
PT1434858E
(pt)
*
|
2002-09-05 |
2008-07-28 |
Bavarian Nordic As |
Método de amplificação de um poxvírus em condições sem soro
|
|
AU2003296974A1
(en)
*
|
2002-12-13 |
2004-07-14 |
Aventis Pasteur, Inc. |
Production of alvac on avian embryonic stem cells
|
|
EP1575601B1
(en)
*
|
2002-12-16 |
2015-07-01 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Recombinant vaccine viruses expressing il-15 and methods of using the same
|
|
US7468273B2
(en)
|
2003-05-01 |
2008-12-23 |
Meial Limited |
Canine GHRH gene, polypeptides and methods of use
|
|
US20060240039A1
(en)
*
|
2003-06-13 |
2006-10-26 |
Isis Innovation Limited |
Vaccines
|
|
WO2005012526A1
(en)
|
2003-08-04 |
2005-02-10 |
The Hospital For Sick Children |
Lafora's disease gene
|
|
ES2417019T3
(es)
|
2003-11-13 |
2013-08-05 |
University Of Georgia Research Foundation, Inc. |
Procedimiento de caracterización del virus de la enfermedad de la bursitis infecciosa
|
|
CA2580305A1
(en)
*
|
2004-06-02 |
2005-12-15 |
The Governors Of The University Of Alberta |
Polymer based nano-carriers for the solubilization and delivery of hydrophobic drugs
|
|
US7998733B2
(en)
|
2004-10-05 |
2011-08-16 |
Merial Limited |
Chimeric vectors
|
|
WO2006115843A2
(en)
*
|
2005-04-25 |
2006-11-02 |
Merial Limited |
Nipah virus vaccines
|
|
US20080241184A1
(en)
|
2005-08-25 |
2008-10-02 |
Jules Maarten Minke |
Canine influenza vaccines
|
|
US7771995B2
(en)
|
2005-11-14 |
2010-08-10 |
Merial Limited |
Plasmid encoding human BMP-7
|
|
EP3147296A1
(en)
|
2005-11-14 |
2017-03-29 |
Merial, Inc. |
Gene therapy for renal failure
|
|
EP3167900B1
(en)
|
2006-03-29 |
2018-11-21 |
Merial Limited |
Vaccine against streptococci
|
|
US7682619B2
(en)
|
2006-04-06 |
2010-03-23 |
Cornell Research Foundation, Inc. |
Canine influenza virus
|
|
US7862821B2
(en)
|
2006-06-01 |
2011-01-04 |
Merial Limited |
Recombinant vaccine against bluetongue virus
|
|
KR20150038558A
(ko)
*
|
2006-11-30 |
2015-04-08 |
탭이뮨, 인크. |
분자 아주반트로서 ｔａｐ―１ 및/또는 ｔａｐ―２를 포함하는 폭스비리대 치료
|
|
EP2147105B1
(en)
|
2007-05-02 |
2013-04-24 |
Merial Limited |
Dna plasmids having improved expression and stability
|
|
US8603808B2
(en)
|
2008-05-08 |
2013-12-10 |
Merial Limited |
Leishmania vaccine using sand fly salivary immunogen
|
|
WO2009155711A1
(en)
|
2008-06-27 |
2009-12-30 |
University Of Guelph |
Analysis of lactobacillus acidophilus la-5 signal interference molecules
|
|
JP2012506699A
(ja)
|
2008-10-24 |
2012-03-22 |
メリアル リミテッド |
アフリカウマ病ウイルスに対するワクチン
|
|
CA2829916C
(en)
|
2011-03-21 |
2019-08-20 |
Vaxin Inc. |
Intranasal administration of an adenovirus vector to induce a protective immune response to an inhalation pathogen
|
|
WO2012145577A1
(en)
|
2011-04-20 |
2012-10-26 |
Merial Limited |
Adjuvanted rabies vaccine with improved viscosity profile
|
|
CA2837375C
(en)
|
2011-06-01 |
2019-07-16 |
Merial Limited |
Needle-free administration of prrsv vaccines
|
|
ES2720150T3
(es)
|
2011-07-20 |
2019-07-18 |
Merial Ltd |
Vacuna recombinante contra el virus de la leucemia felina que contiene un gen optimizado de la envoltura del virus de la leucemia felina
|
|
SI2741740T1
(sl)
|
2011-08-12 |
2017-08-31 |
Merial, Inc. |
Vakuumsko konzerviranje bioloških proizvodov, zlasti cepiv
|
|
US9402894B2
(en)
|
2011-10-27 |
2016-08-02 |
International Aids Vaccine Initiative |
Viral particles derived from an enveloped virus
|
|
CN104203271B
(zh)
|
2012-02-14 |
2017-08-25 |
梅里亚股份有限公司 |
表达狂犬病病毒和ox40蛋白的重组痘病毒载体及从其制造的疫苗
|
|
SG11201405847SA
(en)
|
2012-03-20 |
2014-10-30 |
Merial Inc |
Recombinant equine herpesvirus-1 vaccine containing mutated glycoprotein c and uses thereof
|
|
US10274499B2
(en)
|
2012-03-27 |
2019-04-30 |
The University Of Western Ontario |
SH2 domain variants
|
|
US9347065B2
(en)
|
2012-03-29 |
2016-05-24 |
International Aids Vaccine Initiative |
Methods to improve vector expression and genetic stability
|
|
WO2014141244A1
(en)
|
2013-03-12 |
2014-09-18 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Synthetic peptides for the treatment of autoimmune diseases
|
|
CA2966191A1
(en)
|
2014-11-03 |
2016-05-12 |
Merial, Inc. |
Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus
|
|
EP3042666A1
(en)
|
2015-01-06 |
2016-07-13 |
Rheinisch-Westfälische Technische Hochschule Aachen |
ITIH5 fragments for the treatment of cancer
|
|
ES2903443T3
(es)
|
2015-04-28 |
2022-04-01 |
Avivagen Inc |
Carotenoides oxidados y componentes de los mismos para prevenir la enteritis necrótica
|
|
US20210299245A1
(en)
*
|
2020-03-31 |
2021-09-30 |
Sementis Limited |
Attenuated poxvirus vector based vaccine for protection against covid-19
|
|
CN116656730B
(zh)
*
|
2023-05-25 |
2024-03-19 |
军事科学院军事医学研究院军事兽医研究所 |
一种表达狂犬病病毒g、m蛋白的重组金丝雀痘病毒及其构建方法
|